BioCryst Pharmaceuticals
BCRX
BCRX
123 hedge funds and large institutions have $817M invested in BioCryst Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 40 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
123
Holders Change
+7
Holders Change %
+6.03%
% of All Funds
2.74%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
21
Increased
31
Reduced
40
Closed
14
Calls
$2.1M
Puts
$1.44M
Net Calls
+$657K
Net Calls Change
+$253K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
II
126
Ibex Investors
Denver,
Colorado
| – | -$216K | -28,252 | Closed |
|
|
EMG
127
Ellington Management Group
Old Greenwich,
Connecticut
| – | -$128K | -16,800 | Closed |
|
|
DTL
128
Dynamic Technology Lab
Singapore
| – | -$122K | -16,036 | Closed |
|
|
JT
129
Jump Trading
Chicago,
Illinois
| – | -$111K | -14,500 | Closed |
|
130
Pacer Advisors
Malvern,
Pennsylvania
| – | -$55K | -7,158 | Closed |
|
|
AIM
131
Assured Investment Management
New York
| – | -$40K | -5,282 | Closed |
|
132
Group One Trading
Chicago,
Illinois
| – | -$30K | -3,879 | Closed |
|
|
PCM
133
Prelude Capital Management
New York
| – | -$10K | -1,318 | Closed |
|
134
Walleye Trading
New York
| – | -$9K | -1,245 | Closed |
|
|
KF
135
Krilogy Financial
St. Louis,
Missouri
| – | -$2K | -200 | Closed |
|